Doripenem (Doribax), a new carbapenem antibacterial agent

P and T

Volumn 33, Issue 3, 2008, Pages

  Hilas, Olga ^a,b   Ezzo, Danielle C ^a,c   Jodlowski, Tomasz Z ^a,d  

^a ST JOHN'S UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d JACOBI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACYLASE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; DORIBAX; DORIPENEM; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG; VALPROIC ACID;

ABDOMINAL INFECTION; ACINETOBACTER; ANAPHYLAXIS; ANEMIA; ANTIMICROBIAL ACTIVITY; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; COLITIS; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; DIABETIC FOOT; DIARRHEA; DRUG APPROVAL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCUS; ENZYME DEGRADATION; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INFECTION COMPLICATION; MYCOSIS; NAUSEA; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PHLEBITIS; PNEUMONIA; PSEUDOMONAS AERUGINOSA; SEIZURE; SEPTICEMIA; SHORT SURVEY; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SURGICAL INFECTION; TOXIC EPIDERMAL NECROLYSIS; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 42149095371     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Zhanel G, Wiebe R, Dilay L, et al. Comparative review of the carbapenems. Drugs 2007;67(7):1027-1052.
2. Jones R, Huynh H, Biedenbach D. Activities of doripenem (S-4661) against drug-resistant clinical pathogens. Antimicrob Agents Chemother 2004;48(8):3136-3140.
3. Nakashima M, Kato T, Kimura Y, et al. S-4661, a new carbapenem: IV. Pharmacokinetics in healthy volunteers. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, 32, 1994.
4. Nicasio AM, Kuti JL, Nicolau DP. The current state of multiple-drug resistant gram-negative bacilli in North America: Insights from the Society of Infectious Diseases Pharmacists. Society of Infec tious Diseases Pharmacists Newsletter. Spring 2007;8-20.
5. FDA approves new drug to treat complicated urinary tract and intra-abdominal infections. Available at: www.fda.gov/bbs/topics/NEWS/ 2007/NEW01728.html. Accessed December 10, 2007.
6. Doripenem S-4661. ADIS R&D Profile. Drugs R&D 2003;4(6):363-365.
7. Doribax (doripenem), package insert. Raritan, NJ: Ortho-McNeil; October 2007.
8. Micromedex® Healthcare Series (Internet Database), version 5.1. Greenwood Village, CO: Thomson Micromedex; 2008.
9. Data on file. Ortho-McNeil Janssen Scientific Affairs, LLC, 2007.
10. Chastre J, Wunderink R, Prokocimer P, et al. Efficacy and safety of doripenem versus imipenem for ventilator-associated pneumonia. Poster, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 17-20, 2007.
11. Postier R, Clavel M, Prokocimer P, et al. Efficacy of doripenem versus imipenem in patients with ventilator-associated pneumonia and high disease severity. Poster, 45th Annual Meeting of Infectious Diseases Society of America, San Diego, October 4-7, 2007.
12. Rea-Neto A, Niederman M, Lee M, et al. Efficacy and safety of intravenous doripenem versus piperacillin/tazobactam in nosocomial pneumonia. Poster, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 17-20, 2007.
13. Data on file. Johnson & Johnson Pharmaceutical Research & Development, LLC, 2006.
14. Lunde JL, Nelson RE, Storandt HF. Acute seizure in a patient receiving divalproex sodium after starting ertapenem therapy. Pharmacotherapy 2007;27:1202-1205.
15. Mori H, Takahashi K, Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev 2007;39:647-657.
16. Spriet I, Goyens J, Meersseman W, et al. Interaction between valproate and meropenem: A retrospective study. Ann Pharmacother 2007;41:1130-1136.
17. Weiss ME, Adkinson NF. Beta-lactam allergy. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th ed. New York: Elsevier Churchill Livingstone; 2005:318-326.
18. Anderson DL. Doripenem. Drugs Today 2006;42;399-404.
19. Strategies to Address Antimicrobial Resistance Act (STAAR). Available at: www.idsociety.org/STAARAct.htm. Accessed December 11, 2007.
20. Bad bugs, no drugs as antibiotic discovery stagnates: A public crisis brews. Infectious Diseases Society of America; July 2004. Available at: www.idsociety.org/WorkArea/showcontent.aspx?id=5554. Accessed December 11, 2007.